Last Price
0.017
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Overview
Market Cap
10 Million
Shares Outstanding
631 Million
Avg Volume
381,416
Avg Price (50 Days)
0.02
Avg Price (200 Days)
0.02
PE Ratio
-1.70
EPS
-0.01
Earnings Announcement
26-Feb-2025
Previous Close
0.02
Open
0.02
Day's Range
0.017 - 0.018
Year Range
0.016 - 0.041
Trading Volume
588,234
Price Change Highlight
1 Day Change
0.00%
5 Day Change
-5.56%
1 Month Change
-15.00%
3 Month Change
-26.09%
6 Month Change
-29.17%
Ytd Change
-32.00%
1 Year Change
-15.00%
3 Year Change
-80.00%
5 Year Change
-85.83%
10 Year Change
-93.71%
Max Change
-93.71%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is headquartered in Bundoora, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
Australia Faces Economic Pain From Trump Win, Treasurer Warns
2
CEO Morning Brief
Australia raised Fair Trade in Trump Phone Call, Says PM Albanese
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
